Related by context. All words. (Click for frequent words.) 81 grade gliomas 75 grade cervical dysplasia 74 grade cervical intraepithelial 72 grade dysplasia 69 neoplasia PIN 68 myelodysplastic syndrome MDS 67 density lipoprotein HDL cholesterol 67 dose melphalan 66 dose cytarabine 66 grade prostatic intraepithelial 66 dose dexamethasone 66 dose cyclophosphamide 66 colorectal liver metastases 65 dose atorvastatin 65 smoldering multiple myeloma 65 invasive ductal 65 hyperphenylalaninemia HPA due 65 grade cervical lesions 65 pretest probability 65 ependymoma 65 fallopian tube carcinoma 64 myelodysplastic syndromes MDS 64 epithelial tumors 64 Molecular Weight Heparin 64 Hurthle cell 64 relapsed Acute Myeloid 64 Toxicities 64 histologic subtype 64 gastrointestinal stromal tumor 64 acute GvHD 64 dose methotrexate 64 operable breast cancer 64 leukemia AML 64 grade squamous intraepithelial 64 superficial bladder cancer 64 complement inhibitor eculizumab 64 CIN3 64 colorectal adenoma 64 MALT lymphoma 64 recurrent glioblastoma multiforme 64 HER2 overexpression 64 GISTs 64 astrocytoma 64 platelet reactivity 63 non metastatic osteosarcoma 63 colorectal neoplasms 63 intravesical therapy 63 colorectal carcinoma 63 osteosarcomas 63 TTF Therapy 63 invasive candidiasis 63 B Cell Lymphoma 63 dose ritonavir 63 cervical intraepithelial neoplasia 63 hematologic toxicity 63 hyperoxaluria 63 thromboembolic events 63 advanced adenomas 63 ADPKD 63 CIN2 + 63 thromboembolic complications 63 prostate adenocarcinoma 63 subependymal giant cell 63 penetrance 63 seminoma 63 neoplasia 63 metastatic renal cell carcinoma 63 hepatocellular carcinomas 62 pancreatic adenocarcinoma 62 mRCC 62 urothelial carcinoma 62 dose Iluvien 62 gastric carcinoma 62 WT1 62 dose cohorts 62 metastatic malignant 62 baseline LDH 62 Glioblastoma multiforme GBM 62 Squamous 62 fructose diet 62 Chronic Myelogenous Leukemia CML 62 hypercalcemia 62 B7 H3 62 basal cell carcinoma BCC 62 locoregional recurrence 62 B CLL 62 artery stenosis 62 symptomatic VTE 62 HGPIN 62 metastatic gastric 62 relapsed MM 62 serum phosphate 62 urate levels 62 recurrent glioblastoma multiforme GBM 62 acute leukemias 62 Hydroxyurea 62 cisplatin chemotherapy 62 neutrophil counts 62 fat ketogenic diet 62 mixed hyperlipidemia 62 posterior uveitis 62 dose corticosteroids 62 breast carcinoma 62 serum calcium levels 61 grade astrocytomas 61 neoplasm 61 unresectable tumors 61 Anthracycline 61 haematologic 61 pAkt 61 Relapsing Remitting Multiple Sclerosis 61 differentiated thyroid 61 breast carcinomas 61 pediatric malignancies 61 Hepatocellular Carcinoma HCC 61 TNF antagonist 61 hypercholesterolaemia 61 carotid stenosis 61 endometrial hyperplasia 61 cardiac dysfunction 61 contralateral breast 61 hematopoietic cancers 61 glioblastoma multiforme GBM 61 risk HPV genotypes 61 follicular lymphoma FL 61 Adjuvant chemotherapy 61 inflammatory acne 61 MGd 61 purpura ITP 61 mycophenolate mofetil 61 cytoreductive surgery 61 myeloproliferative disorders 61 febrile neutropenia 61 pertuzumab 61 ductal breast cancer 61 prostate cancer PCa 61 serum creatinine levels 61 cytopenias 61 serum LDL cholesterol 61 cisplatin resistant 61 serum calcium 61 unresectable 61 leukemia ALL 61 dose colchicine 61 dose interleukin 61 DFMO 61 ara C 61 follicular NHL 61 denileukin diftitox 61 atypical hemolytic uremic syndrome 61 gastric adenocarcinoma 61 adenoma recurrence 61 HER2 expression 61 metastatic bladder 61 molecular weight heparins 61 metastatic colorectal 61 Letairis ambrisentan 61 postoperative complication 61 EpCAM expression 61 myeloid leukemia 61 Glioblastoma Multiforme 61 parathyroid carcinoma 61 Nonspecific 61 gastrointestinal cancers 61 polyp recurrence 61 intestinal polyps 61 asymptomatic carotid stenosis 61 intravascular hemolysis 61 esophageal adenocarcinoma 61 serum urate levels 61 prostate carcinoma 61 CYT# potent vascular disrupting 61 homocysteine concentrations 61 leukoencephalopathy 61 CMV infection 61 corticosteroid therapy 61 nephrotoxicity 61 cranial radiation 61 HbF 61 chronic lymphocytic leukemia CLL 61 precancerous cervical 61 Host Disease GvHD 61 recurrent DVT 61 Dasatinib 61 idraparinux 61 Adenomas 61 cardiotoxicity 61 liver metastasis 61 weight heparin LMWH 60 Follicular Lymphoma 60 choroidal neovascularization 60 lupus nephritis 60 unfavorable cytogenetics 60 cervical lesions 60 gastrointestinal stromal tumors GIST 60 cancer mCRC 60 mucinous 60 smoldering myeloma 60 intraventricular hemorrhage 60 PSADT 60 parathyroid 60 hyperkalemia 60 idarubicin 60 paraganglioma 60 histologically confirmed 60 dysplastic lesions 60 colorectal cancer CRC 60 erlotinib Tarceva ® 60 Doxil ® 60 refractory chronic lymphocytic 60 pancreatic NET 60 pCR 60 HNSCC 60 nonmelanoma skin cancers 60 immunomodulatory therapy 60 resectable 60 adjuvant radiotherapy 60 antigen PSA 60 antithrombotic therapy 60 moderate renal impairment 60 curative resection 60 recurrent glioblastoma 60 epithelial ovarian 60 Ribavirin causes 60 deferiprone 60 dexamethasone Decadron 60 meningiomas 60 hepatocellular 60 cervical carcinoma 60 intraepithelial neoplasia 60 riociguat 60 Critical Limb Ischemia CLI 60 myelofibrosis polycythemia vera 60 transplantation HCT 60 hepatorenal syndrome 60 Acute Myeloid Leukaemia AML 60 intracranial hemorrhage ICH 60 basal cell nevus syndrome 60 severe neutropenia 60 small lymphocytic lymphoma 60 clinically localized prostate 60 Decitabine 60 neoplasia CIN 60 IV NSCLC 60 MDS MPD 60 recurrent NSCLC 60 non squamous 60 atherosclerotic lesions 60 carcinoid 60 five MDS subtypes 60 tumor recurrence 60 precursor lesions 60 precancerous cervical lesions 60 grade serous ovarian 60 Myelofibrosis 60 tumor histology 60 Deforolimus 60 valsartan amlodipine 60 vesicoureteral reflux 60 receptor tyrosine kinase inhibitor 60 NovoTTF 60 systemic toxicity 60 metastatic malignant melanoma 60 metastatic renal 60 dose clopidogrel 60 proliferative diabetic retinopathy 60 trans retinoic acid 60 soft tissue sarcomas 60 Cholangiocarcinoma 60 epithelial ovarian cancer 60 myelodysplastic myeloproliferative diseases 60 TMP SMX 60 EBRT 60 hypereosinophilic syndrome 60 radioiodine therapy 60 fluvastatin 60 distant metastasis 60 malignant lymphoma 60 LHRH receptor positive 60 carcinomatosis 60 anterior uveitis 60 secondary hyperparathyroidism 60 locoregional 60 amino acid homocysteine 60 Fludarabine 60 retinal vein occlusion 60 STRIDE PD 60 nonalcoholic steatohepatitis NASH 60 intravenous cyclophosphamide 60 acute myelogenous leukemia AML 60 lymphocytic leukemia 60 endometrial carcinoma 60 Nilotinib 60 transaminase levels 60 peripheral sensory neuropathy 60 Chronic lymphocytic leukemia 60 stage IIIB 60 cervical lymph nodes 60 INCB# [003] 60 IFN beta 60 neuroblastomas 59 dose regimens 59 membranous nephropathy 59 alemtuzumab treated 59 tumors GIST 59 Vidaza ® 59 Mantle Cell Lymphoma 59 histological subtype 59 Hodgkin lymphoma NHL 59 Philadelphia Chromosome Positive 59 antiepileptic medications 59 ovarian carcinoma 59 idiopathic thrombocytopenic purpura ITP 59 invasive fungal infections 59 malignant neoplasm 59 neoplasias 59 AAT deficiency 59 node metastases 59 biochemical recurrence 59 gallium nitrate 59 varices 59 Carcinoma 59 candidemia 59 Wegener granulomatosis 59 ximelagatran 59 Malignant Glioma 59 teriflunomide 59 papillary renal cell carcinoma 59 Mitoxantrone 59 metastatic lung cancer 59 cranial irradiation 59 anthracycline chemotherapy 59 non squamous NSCLC 59 Hodgkin lymphoma HL 59 renal tumors 59 thromboembolism 59 Blood Cholesterol 59 Anaplastic 59 Glioblastoma Multiforme GBM 59 antihypertensive therapy 59 sarcomatoid 59 urolithiasis 59 postoperative mortality 59 elevated creatinine 59 Dapagliflozin 59 proliferative retinopathy 59 neuroendocrine tumors 59 subclinical hypothyroidism 59 neuroendocrine carcinoma 59 astrocytomas 59 T1a 59 acute lymphoblastic 59 Glioma 59 atypical hyperplasia 59 Azacitidine 59 direct thrombin inhibitors 59 CTEPH 59 rFVIIa 59 relapsed ovarian cancer 59 blood phenylalanine Phe 59 immunopathology 59 primary hyperparathyroidism 59 cell lymphoma ALCL 59 lung carcinomas 59 E selectin 59 chemoradiotherapy 59 plasma triglycerides 59 ANCA associated 59 Neovascular Age Related Macular 59 renal cell carcinomas 59 pulmonary metastases 59 pheochromocytoma 59 malignant fibrous histiocytoma 59 HER2 positive cancers 59 urothelial cancer 59 neovascular diseases 59 HIV HCV coinfected 59 tumor hypoxia 59 CLL SLL 59 BRAF mutations 59 homozygous familial hypercholesterolemia 59 autoimmune thyroiditis 59 Gliomas 59 transferrin saturation 59 elevated serum creatinine 59 thyroglobulin 59 antigen PSA levels 59 Natalizumab 59 severe oral mucositis 59 carotid artery stenting 59 HSCT 59 bacterial prostatitis 59 RAS mutations 59 chronic eosinophilic leukemia 59 ovarian lung 59 allograft rejection 59 fallopian tube cancers 59 temsirolimus 59 Atypical Hemolytic Uremic Syndrome 59 gastrointestinal stromal tumor GIST 59 dose Ara 59 cell chronic lymphocytic 59 glycated hemoglobin levels 59 CMV reactivation 59 endometrial cancers 59 HBeAg negative 59 Gleevec resistant 59 atypical Hemolytic Uremic Syndrome 59 IV bisphosphonates 59 leucopenia 59 standard chemotherapy regimens 59 Cutaneous T 59 graft dysfunction 59 endometrioid 59 metachronous 59 CIN2 59 XIENCE V PROMUS Stent 59 adrenocortical cancer 59 imatinib therapy 59 dasatinib 59 phase IIb trial 59 hyperparathyroidism 59 cinacalcet 59 deep venous thromboses 59 squamous cell carcinoma SCC 59 chronic thromboembolic pulmonary 59 triiodothyronine 59 myelosuppression 59 vertebral fracture 59 neuroblastoma tumors 59 panobinostat 59 AA Amyloidosis 59 refractory rituximab naive 59 esophagitis 59 endocrine tumors 59 neutropaenia 59 PEGylated interferon beta 1a 59 Acute Myelogenous Leukemia AML 59 Erlotinib 59 EGFR HER2 59 HER2 positive metastatic breast 59 hepatic cirrhosis 59 ischemic lesions 59 aHUS 59 Severe Primary IGFD 59 Amrubicin 59 thrombotic complications 59 Pulmonary hypertension 59 vWD 59 vWF 59 adjuvant radiation 59 SHPT 59 PSA nadir 59 chemoradiation 59 fetuin 59 Myelodysplastic Syndrome MDS 59 deletion 5q 59 squamous cell lung cancer 59 cerebral vasospasm 59 dasatinib Sprycel 59 demonstrated antitumor activity 59 Cervista HPV HR 59 elevated triglyceride levels 59 familial hypercholesterolemia FH 59 microvascular complications 59 immune thrombocytopenic purpura ITP 59 prostate cancer CaP 59 Astrocytoma 59 TNF alpha antagonist 59 refractory NSCLC 59 indolent NHL 59 generalized epilepsy 59 bladder cancers 59 residual platelet reactivity 59 glial tumors 59 pT2 59 generalized seizures 59 bevacizumab Avastin ® 59 post transplant lymphoproliferative 59 nanomolar 58 peritoneal carcinomatosis 58 recurrent metastatic 58 Cell Lymphoma 58 serous ovarian cancer 58 distant metastases 58 hematologic disorders 58 completely resected 58 patients undergoing CABG 58 prognostic variables 58 LHRH agonists 58 xenograft models 58 recurrent UTI 58 severe exacerbations 58 demethylation agents 58 docetaxel chemotherapy 58 psoriatic arthritis PsA 58 situ CIS 58 aminotransferase ALT 58 metastatic GIST 58 thalidomide Thalomid 58 peritumoral brain edema 58 surrogate endpoint 58 azacytidine 58 dysplasias 58 Leukemias 58 coronary stenosis 58 paroxysmal AF 58 bronchogenic carcinoma 58 corticosteroid dexamethasone 58 octreotide LAR 58 stratifying patients 58 N telopeptide 58 Lenalidomide 58 adrenalectomy 58 idiopathic pulmonary fibrosis IPF 58 forodesine 58 postoperative AF 58 ovarian tumors 58 chemoradiation therapy 58 density lipoprotein cholesterol HDL 58 thyrotropin levels 58 chlamydial infection 58 follicular lymphoma 58 EGFR TKI 58 Metastases 58 Candida infections 58 Hashimoto thyroiditis 58 diffuse gastric 58 myeloablative 58 Chronic lymphocytic leukemia CLL 58 thyroid stimulating hormone 58 lung pancreatic 58 primary hypercholesterolemia 58 laser therapy LLLT 58 ritonavir boosted 58 malignant pleural mesothelioma 58 T1c 58 MYCN amplification 58 allogeneic HSCT 58 troponin T 58 invasive aspergillosis 58 Glioblastomas 58 refractory anaplastic astrocytoma 58 leiomyomas 58 prolonged QT interval 58 renal scarring 58 NAGS deficiency 58 Folfox 58 paricalcitol 58 carcinoid tumors 58 lowering blood glucose 58 azacitidine 58 myopathy rhabdomyolysis 58 relapsing remitting MS RRMS 58 T1DM 58 anaplastic astrocytomas 58 Lung transplantation 58 non splenectomized 58 diabetes mellitus DM 58 diffuse intrinsic pontine glioma 58 efaproxiral 58 metastatic kidney 58 transitional cell carcinoma 58 Gleevec imatinib 58 CTAP# Capsules 58 protein kinase inhibitor 58 Papillary 58 thrombocytopenic 58 generation purine nucleoside 58 daunorubicin 58 Cardiotoxicity 58 androgen deprivation 58 hepatocellular carcinoma 58 imatinib resistance 58 heavily pretreated 58 BRCA1 BRCA2 58 Myelodysplastic Syndrome 58 Omacetaxine 58 Circulating tumor cells 58 hepatic metastases 58 taxane resistant 58 acute myeloid 58 adenoma 58 transfusion syndrome 58 dose statin therapy 58 Metastatic 58 myeloproliferative diseases 58 thyrotoxicosis 58 cediranib 58 Chronic Myeloid Leukemia 58 recurrent VTE 58 sorafenib Nexavar 58 BMPR2 58 bone metastasis 58 hypercholesterolemia 58 cell lymphoma CTCL 58 cell carcinoma 58 CIMZIA ™ 58 leukopenia 58 VAPRISOL 58 anaplastic astrocytoma 58 Alessandro Riva 58 relapsing multiple sclerosis 58 Vidofludimus 58 heparin induced thrombocytopenia 58 sarcomas 58 taxane therapy 58 TAXUS Express Stent 58 anaplastic 58 alanine aminotransferase 58 ventricular tachyarrhythmia 58 myelodysplasia 58 BRCA mutation carriers 58 Naive Patients 58 Juvenile Idiopathic Arthritis 58 nonsmall cell lung cancer 58 pan HDAC inhibitor 58 dose ionizing radiation 58 chronic myeloid 58 premalignant lesion 58 skeletal metastases 58 Acute myeloid leukemia 58 5-FU/LV 58 Glioblastoma multiforme 58 malignant growths 58 Soft Tissue Sarcoma 58 cilengitide 58 colorectal neoplasia 58 PCA3 scores 58 hepatocellular carcinoma liver 58 luteinizing hormone releasing 58 SHBG levels 58 cell carcinoma RCC 58 neutropenic 58 cholangiocarcinoma 58 colorectal pancreatic 58 Sorafenib 58 ocular disorders 58 Bevacizumab 58 carcinoids 58 intra ocular pressure 58 liposomal amphotericin B 58 cutaneous squamous cell carcinoma 58 papillary thyroid carcinoma 58 stenoses 58 Acute Myelogenous Leukemia 58 renal cell carcinoma 58 Aortic stenosis 58 stage IIIb IV 58 sodium glucose cotransporter 58 eosinophilic asthma 58 cellularity 58 p# biomarker 58 decitabine 58 choroidal neovascularization CNV 58 moderate ulcerative colitis 58 colon tumors 58 chronic idiopathic thrombocytopenic purpura 58 neurological manifestations 58 adenomatous 58 variceal hemorrhage 58 irinotecan chemotherapy 58 Pseudomonas aeruginosa infections 58 tumors 58 atherosclerotic disease 58 Antitumor Activity 58 familial hypercholesterolemia 58 peritoneal cancer 58 ischemic cardiomyopathy 58 pT3 58 polycythemia vera essential thrombocythemia 58 vandetanib 58 Flu Cy 58 prolongs survival 58 hamartomas 58 HeFH 58 abacavir Ziagen 58 catheter angiography 58 hemodialysis patients 58 immune thrombocytopenic purpura 58 EGFR inhibitors 58 metastatic pancreatic 58 cytotoxic chemotherapy 58 investigational monoclonal antibody 58 doxorubicin docetaxel 58 AST ALT 58 atherothrombotic events 58 Enzastaurin 58 recurrent glioma 58 myelofibrosis MF 58 paclitaxel cisplatin 58 Hematologic 58 alveolar rhabdomyosarcoma 58 platelet inhibition 58 Teriflunomide 58 leiomyosarcoma 58 mesotheliomas 58 leukemia CLL 58 variceal bleeding 58 mg/m2 dose 58 Waldenstrom macroglobulinemia 58 systemic amyloidosis 58 premalignant 58 Metastatic Colorectal Cancer 58 H. pylori eradication 58 brain metastases 58 tumor xenograft models 58 idiopathic thrombocytopenic purpura 58 preoperative chemotherapy 57 hyperammonemia 57 alkylating agents 57 elevated LDL cholesterol 57 VEGF inhibitors 57 BRAF inhibitor 57 serum IGF 57 arterial thromboembolic events 57 Belldegrun 57 serum HBV DNA 57 BARACLUDE ® 57 postoperative chemotherapy 57 Radiofrequency ablation 57 mutated KRAS 57 neovascular 57 GnRH agonists 57 bilirubin levels 57 vinca alkaloid 57 Hyperlipidemia 57 recurrent ovarian cancer 57 elevated CRP 57 virological failure 57 bullous 57 malignant polyps 57 Erythropoietic therapies may 57 TACE 57 anovulation 57 FOLFOX4 57 protease inhibitors PIs 57 prostate abnormalities 57 PHPT 57 esophageal candidiasis 57 malignant pancreatic 57 Relapsed Refractory 57 prostate carcinomas 57 renal artery stenosis 57 thyroid nodules 57 lymphoid tumors 57 oral antidiabetic medication 57 del 5q 57 NMIBC 57 cardiac toxicity 57 leukemias lymphomas 57 angiogenesis inhibitor 57 serum clusterin levels 57 lymphoblastic leukemia 57 VEGF expression 57 nodal metastasis 57 paragangliomas 57 Myelodysplastic Syndromes 57 pegfilgrastim 57 BEACOPP 57 pericardial effusion 57 Malignant Melanoma 57 severe mitral regurgitation 57 CXCR4 expression 57 hematological diseases 57 symptomatic intracranial hemorrhage 57 systemic anaplastic large 57 pulmonary hypertension PH 57 symptomatic paroxysmal AF 57 radiotherapy RT 57 Sjögren syndrome 57 oral Hycamtin 57 PCNSL 57 metastatic cancer 57 antiangiogenic agent 57 Aliskiren 57 DIPG 57 autoantibody positive 57 elevated LDH 57 ZOLINZA 57 PCa 57 invasive lobular 57 relapsing remitting multiple sclerosis 57 prognostic indicator 57 metastatic neuroendocrine tumors 57 gastric cancers 57 breast endometrial 57 Eculizumab 57 KRAS status 57 pancytopenia 57 dose cohort 57 infliximab Remicade 57 FDG PET imaging 57 expressors 57 cTnI 57 SCCHN 57 diabetic kidney 57 Bezielle 57 radiosensitivity 57 FVIIa 57 malignant lymphomas 57 extracranial 57 angiotensin converting enzyme inhibitors 57 Hurler syndrome 57 infective endocarditis 57 Acute Myeloid Leukemia AML 57 lipid elevations 57 cirrhotic patients 57 cervical precancer 57 CLL cells 57 Chronic Lymphocytic Leukemia 57 platelet counts 57 esophageal squamous cell carcinoma 57 EBV infection 57 CMV infections 57 hyperalgesia 57 Bronchiectasis 57 tuberous sclerosis TS 57 middle ear effusion 57 intractable epilepsy 57 serum prostate 57 colorectal adenomas 57 stable angina pectoris 57 Hepatocellular Carcinoma 57 gefitinib Iressa 57 biliary tract 57 bladder carcinoma 57 LRP5 57 hypervascular tumors 57 transcranial Doppler 57 Neoadjuvant 57 neuroblastoma tumor 57 imatinib Gleevec ® 57 rebleeding 57 Leukemia AML 57 BCR ABL mutations 57 TRAIL R1 57 Femara letrozole 57 eculizumab therapy 57 bevacizumab Avastin 57 gemcitabine carboplatin 57 liposomal doxorubicin 57 macroalbuminuria 57 radiochemotherapy 57 uterine tumors 57 Thrombotic thromboembolic complications 57 aminotransferase levels 57 medically inoperable 57 interferon alfa 2b 57 Neutropenia 57 ductal adenocarcinoma 57 Basal cell 57 antidiabetic drugs 57 lactate dehydrogenase LDH 57 lupus erythematosus 57 familial amyloidotic polyneuropathy FAP 57 venous thromboembolism 57 leukaemic stem cells 57 TTR amyloidosis 57 mutated KRAS gene 57 serum uric acid 57 complete cytogenetic response 57 docetaxel Taxotere ® 57 Vandetanib 57 nasopharyngeal carcinoma 57 glycosylated hemoglobin HbA1c 57 Vicinium TM 57 keloid scarring 57 ACTEMRA TM 57 de novo AML 57 Gliadel Wafer 57 abdominal adiposity 57 Crohn disease CD 57 glomerular filtration 57 Chronic ITP 57 Rev Dex 57 SGPT 57 d4T stavudine Zerit 57 recurrent venous thromboembolism 57 upper gastrointestinal bleeding 57 ertapenem 57 prognostic indicators 57 colon carcinoma 57 PTLD 57 cardiac troponin 57 gastrointestinal stromal tumors GISTs 57 proteasome inhibitors 57 gastrointestinal stromal tumors 57 Capecitabine 57 adenomatous polyps 57 pancreatic carcinoma 57 renal carcinoma 57 neovascular glaucoma 57 diagnostic biomarker 57 carotid atherosclerosis 57 Cloretazine 57 nonalcoholic steatohepatitis 57 leukaemias 57 induce remission 57 unfractionated heparin UFH 57 ovarian malignancy 57 ULORIC 57 malignancies 57 refractory gout 57 acute humoral rejection 57 Nexavar sorafenib 57 antiepileptic drugs AEDs 57 nonmetastatic 57 FOLFOX6 57 rosuvastatin #mg 57 calcitriol 57 pelvic radiotherapy 57 pulmonary arterial pressures 57 inhibitor RG# 57 conventional DMARDs 57 PASI scores 57 antiphospholipid syndrome 57 cutaneous melanoma 57 biliary tract cancer 57 Xelox 57 atrioventricular block 57 chemotherapeutic regimens 57 R lenalidomide 57 alvespimycin 57 tumoral 57 atypical ductal hyperplasia 57 bone marrow suppression 57 postoperative atrial fibrillation 57 malignant ascites 57 indolent follicular non 57 epirubicin 57 lymphopenia 57 autologous transplants 57 Ranibizumab 57 lymphoma subtypes 57 Chronic Lymphocytic Leukemia CLL 57 Metastatic Prostate Cancer 57 intravenous bisphosphonates 57 Eisenmenger syndrome 57 Vidaza azacitidine 57 Xanafide 57 hA# 57 lymphoproliferative disorder 57 neurodevelopmental impairment 57 hypophosphatemia 57 leukocytosis 57 FOLFIRI 57 idiopathic PAH 57 T2DM 57 elevated ALT 57 NQO1 57 bazedoxifene conjugated estrogens 57 ventricular dysfunction 57 neuroendocrine cancers 57 immunosuppressive regimen 57 basiliximab 57 prostate cancer HRPC 57 antiarrhythmic drug 57 RBC folate 57 alkylating agent 57 pituitary adenomas 57 phase IIb clinical 57 MCyR 57 corticosteroid dose 57 chronic immune thrombocytopenic 57 Gorlin syndrome 57 transgene expression 57 carcinoid tumor 57 paroxysmal nocturnal hemoglobinuria PNH 57 liver histology 57 flavopiridol 57 pseudotumor cerebri 57 EpCAM 57 aspartate aminotransferase AST 57 adnexal mass 57 Tyrima 57 ependymomas 57 neoplastic lesions 57 latent tuberculosis infection 57 follicular thyroid cancer 57 histone deacetylase HDAC inhibitor 57 CsA 57 allogeneic stem cell 57 receiving Vectibix monotherapy 57 morphometric vertebral fractures 57 FluCAM arm 57 organ transplant rejection 57 visilizumab 57 Safinamide 57 metastatic RCC 57 systemic lupus erythematosus SLE 57 cystatin C 57 cell acute lymphoblastic 57 Fludara ® 57 occlusive disease 57 gastrointestinal GI cancers 57 Non Alcoholic Fatty 57 Castration Resistant Prostate Cancer 57 advanced adenoma